全身性肥満細胞症
WordNet
- (physical chemistry) a sample of matter in which substances in different phases are in equilibrium; "in a static system oil cannot be replaced by water on a surface"; "a system generating hydrogen peroxide"
- instrumentality that combines interrelated interacting artifacts designed to work as a coherent entity; "he bought a new stereo system"; "the system consists of a motor and a small computer"
- a group of independent but interrelated elements comprising a unified whole; "a vast system of production and distribution and consumption keep the country going" (同)scheme
- a complex of methods or rules governing behavior; "they have to operate under a system they oppose"; "that language has a complex system for indicating gender" (同)system of rules
- a group of physiologically or anatomically related organs or parts; "the body has a system of organs for digestion"
- a procedure or process for obtaining an objective; "they had to devise a system that did not depend on cooperation"
- the living body considered as made up of interdependent components forming a unified whole; "exercise helped him get the alcohol out of his system"
- small room in which a monk or nun lives (同)cubicle
- a device that delivers an electric current as the result of a chemical reaction (同)electric cell
- a room where a prisoner is kept (同)jail cell, prison cell
- (biology) the basic structural and functional unit of all organisms; they may exist as independent units of life (as in monads) or may form colonies or tissues as in higher plants and animals
- any small compartment; "the cells of a honeycomb"
- a small unit serving as part of or as the nucleus of a larger political movement (同)cadre
- an impairment of health or a condition of abnormal functioning
- nuts of forest trees (as beechnuts and acorns) accumulated on the ground
- a vertical spar for supporting sails
- any sturdy upright pole
- nuts of forest trees used as feed for swine
- affecting an entire system; "a systemic poison"
PrepTutorEJDIC
- 〈C〉(関連した部分から成る)『体系』,系統,組織[網],装置 / 〈C〉(教育・政治などの)『制度』,機構;《the~》体制 / 〈C〉(思想・学問などの)『体系』,学説 / 〈C〉(…の)『方法』,方式,やり方《+of doing》 / 〈U〉正しい方針(筋道,順序) / 〈U〉《the~》(身体の)組織,系統 / 〈U〉《the~,one's~》身体,全身
- (刑務所の)『独房』;(修道院の)小さい独居室 / (ミツバチの)みつ房,巣穴 / 小さい部屋 / 『細胞』 / 電池 / 花粉室 / (共産党などの)細胞
- (体の)『病気』,疾患 / (精神・道徳などの)病気,病弊
- 女性の話術芸人 =diseur
- 『マスト』,帆柱 / (装飾用の)高い柱;(無電用・起重機用の)鉄塔
- ブナ(クリ・カシワなど)の実(豚の飼料にする)
- (身体・言語のように)体系の,組織の / 全身の,全身的
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Immunology and clinical manifestations of non-clonal mast cell activation syndrome.
- Cardet JC, Castells MC, Hamilton MJ.SourceDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
- Current allergy and asthma reports.Curr Allergy Asthma Rep.2013 Feb;13(1):10-8. doi: 10.1007/s11882-012-0326-8.
- There is a spectrum of disorders that clinically manifest as a result of mast cell activation. A non-clonal form has emerged in the literature where many of the clinical features of systemic mastocytosis are shared despite having a distinct mast cell biology. In this review, we summarize key feature
- PMID 23212667
- Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression.
- Verstovsek S.SourceDepartment of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
- European journal of haematology.Eur J Haematol.2013 Feb;90(2):89-98. doi: 10.1111/ejh.12043.
- Apart from indolent systemic mastocytosis (SM), which is associated with a favorable prognosis, other subtypes of SM (SM with associated clonal hematologic non-mast cell lineage disease, aggressive SM, and mast cell leukemia - collectively referred to in this review as advanced SM) can be debilitati
- PMID 23181448
- Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function.
- Lin TK, Man MQ, Santiago JL, Park K, Roelandt T, Oda Y, Hupe M, Crumrine D, Lee HJ, Gschwandtner M, Thyssen JP, Trullas C, Tschachler E, Feingold KR, Elias PM.Source1] Dermatology Service, Department of Veterans Affairs Medical Center, and Department of Dermatology, UCSF, San Francisco, California, USA [2] Department of Dermatology, National Cheng Kung University Hospital, and Graduate Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- The Journal of investigative dermatology.J Invest Dermatol.2013 Feb;133(2):469-78. doi: 10.1038/jid.2012.335. Epub 2012 Sep 27.
- Systemic antagonists of the histamine type 1 and 2 receptors (H1/2r) are widely used as anti-pruritics and central sedatives, but demonstrate only modest anti-inflammatory activity. Because many inflammatory dermatoses result from defects in cutaneous barrier function, and because keratinocytes expr
- PMID 23014339
Japanese Journal
- Mucosal Immune Responses in W/W^v and SI/SI^d Mutant Mice
- YOSHINO Naoto,KANNO Hiroyuki,TAKAHASHI Kiyomi [他],ENDO Masahiro,SATO Shigehiro
- Experimental animals 61(4), 407-416, 2012-07-01
- … In order to identify potential unanticipated side reactions and immune responses, the evaluation of candidate vaccines should include immunization of the murine model of the disease in question and mutant animals, as well as normal laboratory animals. … We employed WBB6F1-W/Wv and WBB6F1-Sl/Sld mutant mice, which are genetically mast cell deficient and lack intestinal pacemaker activity due to a severe deficiency in interstitial cells of Cajal. …
- NAID 10030800432
- Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases
- Molderings Gerhard J.,Raithel Martin,Kratz Felix,Azemar Marc,Haenisch Britta,Harzer Sabrina,Homann Jürgen
- Internal Medicine 50(6), 611-615, 2011
- … We report on the outcome of 4 patients with therapy-resistant systemic mast cell activation disease (MCAD) treated with the anti-IgE monoclonal antibody omalizumab in compassionate use. … In the fourth patient omalizumab treatment had to be discontinued due to intolerable mast cell mediator-induced symptoms. … In conclusion, omalizumab can lessen the intensity of the symptoms of systemic MCAD. …
- NAID 130000649895
- Mosla dianthera Decreases Immediate-Type Allergic Reaction and Tumor Necrosis Factor-α Production
- Kim Sang-Hyun,Jeon Hoon,Lee Soyoung [他],Son Hee-Young,Park Seung-Bin,Kim Mi-Sun,Choi Eun-Ju,Lim Jong-Pil,Eun Jae-Soon,Park Jeong-Suk,Shin Tae-Yong
- Journal of health science 54(4), 416-422, 2008-08-01
- … The discovery of drugs for the treatment of allergic disease is an important subject in human health. … Stimulation of mast cells releases inflammatory mediators, such as histamine, and proinflammatory cytokines with immune regulatory properties. … dianthera) (Maxim) (AEMD) on the immediate-type allergic reaction and studied its possible mechanisms of action using the model of mast cell-mediated allergic reaction. …
- NAID 110006835687
Related Links
- Systemic mast cell disease symptoms, causes, diagnosis, and treatment information for Systemic mast cell disease (Mastocytosis) with alternative diagnoses, full-text book chapters, misdiagnosis, research treatments, prevention ...
- Systemic mast cell activation disease (MCAD) comprises disorders characterized by an enhanced release of mast cell mediators accompanied by accumulation of dysfunctional mast cells. Demonstration of familial ...
★リンクテーブル★
[★]
無痛性全身性マスト細胞症、無痛性全身性肥満細胞症
- 関
- aggressive systemic mastocytosis、systemic mast-cell disease、systemic mastocytosis
[★]
侵襲性全身性肥満細胞症
- 関
- indolent systemic mastocytosis、systemic mast-cell disease、systemic mastocytosis
[★]
- 疾患：illnessより厳密な概念。「ある臓器に明確な障害が確認され、それによって症状が出ているとはっきり説明できる場合」 (PSY.9)
- 特定の原因、病態生理、症状、経過、予後、病理組織所見が全てそろった場合 (PSY.9)
- something that is very wrong with people's attitudes, way of life or with society.
- 関
- ail、ailment、disease entity、disorder、ill、illness、malady、sick、sickness
- disease ≠ illness ≠ disorder
[★]
- 関
- general、generalized、systemically、total body、whole body、whole-body
[★]
- 関
- method、series、strain
[★]
[★]
細胞